PFG Investments »

Protalix Biotherapeutics shares owned by PFG Investments

Quarter-by-quarter ownership of Protalix Biotherapeutics (PLX) shares owned by PFG Investments from 13F filings

Historical chart of PFG Investments investment in Protalix Biotherapeutics

Tip: Access up to 7 years of quarterly data

All positions including Protalix Biotherapeutics held by PFG Investments consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Protalix Biotherapeutics by PFG Investments

Quarter filed Position value Share count Share price at filing
2024-12-31 $39k 21k 1.88

More positions owned by PFG Investments

Apple (AAPL)
NVIDIA Corporation (NVDA)
Microsoft Corporation (MSFT)
Tesla Motors (TSLA)
Amazon (AMZN)
Meta Platforms Cl A (META)
Pimco Dynamic Income SHS (PDI)
Spdr S&p 500 Etf Tr Tr Unit (SPY)
JPMorgan Chase & Co. (JPM)
Pimco Etf Tr Enhancd Short (EMNT)
Johnson & Johnson (JNJ)
Palantir Technologies Cl A (PLTR)
Invesco Qqq Tr Unit Ser 1 (QQQ)
Alphabet Cap Stk Cl A (GOOGL)
Costco Wholesale Corporation (COST)

View all positions for PFG Investments

Top funds holding Protalix Biotherapeutics

BlackRock
Opaleye Management
Renaissance Technologies
Northern Trust
Geode Capital Management
Stratos Wealth Partners
State Street Corporation
Vanguard Group
Morgan Stanley
Connor, Clark & Lunn Investment Management
UBS Group
Bridgeway Capital Management
Diametric Capital
Charles Schwab Investment Management
Commonwealth Equity Services

View all funds holding Protalix Biotherapeutics